Kadimastem
VerifiedA clinical stage biotech company using A cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, & Bio-Banking of human functional cells.
Launch date
Employees
Market cap
ILS20.1m
Net debt
(ILS2.2m)
Enterprise valuation
$6m (Public information from Jun 2024)
Share price
ILS4.981 KDST.TA
Company register number 514192558
Sapir South District (HQ)
| ILS | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
Related Content
Recent News about Kadimastem
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.